Skip to main content

and
  1. No Access

    Article

    Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia

    Tyrosine kinase inhibitors (TKIs) have well-characterized immunomodulatory effects on T and NK cells, but the effects on the humoral immunity are less well known. In this project, we studied TKI-induced change...

    Hanna L. M. Rajala, Mohamed El Missiry in Journal of Cancer Research and Clinical On… (2017)